Men's Mental Health and Hormones: Depression, Anxiety, and the Biology Behind Them

Depression and anxiety in men often present differently than the DSM-style checklist suggests. Fatigue, irritability, loss of drive, sleep disturbance, alcohol use, physical aches, and reduced libido are frequently the presenting symptoms — sadness may be entirely absent or only recognized in hindsight. The result is under-diagnosis and under-treatment.

This is compounded by the fact that hormonal, thyroid, and sleep pathology can produce the same symptom pattern. A careful workup treats the person, not the label.

Hypogonadism. Men with confirmed low testosterone score higher on depression scales in observational studies; testosterone repletion in hypogonadal men improves depressive symptoms in randomized trials. In men with normal testosterone, exogenous testosterone does not treat depression and should not be used off-label for that purpose.

Thyroid disease. Both hypothyroidism (low mood, fatigue, cognitive slowing) and hyperthyroidism (anxiety, insomnia, irritability) mimic primary mental-health disorders. A TSH plus free T4 belongs in every mental-health workup.

Cortisol dysregulation. Chronic stress flattens the diurnal cortisol curve and is associated with anxiety, depression, sleep disturbance, and metabolic changes. Adrenal insufficiency and Cushing's are rare but should be considered when the picture doesn't fit.

Vitamin D and B12 deficiency. Both are common, cheap to test, and associated with depressive symptoms; correction is a reasonable adjunct even where causation is uncertain.

Insomnia doubles the risk of new-onset depression. Obstructive sleep apnea drives both mood symptoms and testosterone suppression, and treating it with CPAP improves both. Cognitive behavioral therapy for insomnia (CBT-I) outperforms sleep medications for chronic insomnia and produces durable improvements in mood.

Any workup for depression or anxiety in a man that does not include a sleep history is incomplete.

For moderate-to-severe depression, first-line treatment is a combination of psychotherapy (CBT, interpersonal therapy, or behavioral activation) plus, when indicated, an SSRI or SNRI. Effect sizes are similar; combined treatment outperforms either alone for many men.

Exercise is a legitimate first-line intervention for mild-to-moderate depression, with effect sizes in trials comparable to SSRIs and durable benefits when maintained. Both aerobic and resistance exercise show benefit; the best exercise is the one a person will actually do 3–4x per week.

Newer options — ketamine, esketamine, and psilocybin-assisted therapy — are being integrated into treatment-resistant care under specialist supervision. They are not first-line and should not be pursued outside supervised protocols.

Well-supported: omega-3 fatty acids (particularly EPA-predominant formulas) as an adjunct in depression; vitamin D repletion in the deficient; magnesium in the deficient; standardized ashwagandha (KSM-66 or Sensoril) for stress and anxiety; L-theanine for situational anxiety.

Modest evidence: saffron extract for mild depression; Rhodiola for stress-related fatigue; St. John's Wort for mild depression (with major drug-interaction concerns, especially with SSRIs — do not combine).

Not a substitute for care. Supplements are adjuncts, not replacements. Any man with persistent low mood, hopelessness, or thoughts of self-harm needs professional evaluation, not another bottle.

Thoughts of self-harm or suicide, a sudden change in mood or behavior, hopelessness that persists more than two weeks, or new depressive symptoms after a life event (job loss, divorce, bereavement) are all reasons to seek professional care rather than wait it out. In the US, 988 reaches the Suicide and Crisis Lifeline 24/7.